Introduction: Low-dose thalidomide is an effective treatment option for chronic cutaneous lupus erythematosus(CCLE) in resistant cases.Rarely, it can cause thrombocytopenia. Clinical Summary: A 39 year old female…
NSCLC) is the most common form of lung cancer. Numerous evidences had shown that thalidomide has potential for the inhibition and therapy of cancer. The present study aimed to investigate ... anti-tumor effect of novel…
compares Efavirenz, marketed as Sustiva to the known anti-angiogenic and anti-cancer agent, thalidomide. With animal ethics clearance (No 2008/7/1), 30 chicks chorioallantoic membrane (CAM) was used ... test the effect…
Novel thalidomide dithiocarbamate analogs were synthesized in good yield. A two-step synthesis was utilized to obtain the new thalidomide dithiocarbamate analogs by reaction of thalidomide with 1,2 dichloroethane…
renal systems that limit its therapeutic use. This study examined in rats whether thalidomide, a known antiinflammatory agent with TNF-α inhibitory, immunomodulatory and anti-angiogenic properties could ameliorate…
Thalidomide is an immunomodulatoryagent with anti-inflammatory activity, however it may also cause serious side effects. New compounds derived from thalidomide effective in modulating inflammatory responses and having…
promising strategies in the treatment of cancer. The anti- angiogenetic property of thalidomide has inspired a second wave of research on this teratogenic drug. The aim of the current study ... investigate the…
Thalidomide (TD) is the drug in clinical use since over half a century for variable indications such as Leprosy. In 1960s, the use of TD lead to birth of about ... babies with phocomelia. Later on, TD was removed from…
compares Efavirenz, marketed as sustiva to the known anti-angiogenic and anti-cancer agent, thalidomide. With animal ethics clearance (No 2008/7/1), 30 chick chorioallantoic membrane (CAM) were used ... test the effect…
Thalidomide is perhaps one of the most notorious drugs ever to have been used in clinical practice. The distressing teratogenicity resulted in sudden withdrawl of the drug about 55 years ... back. Recently, thalidomide…
lesions continue exacerbation despite with anti-mycobacterial treatment. But rapid clinical remission occurred after thalidomide adding to the antituberculosis treatment. Furthermore, immunomodulatory effect of…
Abstract Background: To assess the viability and averageness of capecitabine joined together with thalidomide in patients with propelled pancreatic disease (APC) who have beforehand accepted gemcitabine-based treatment…
incidence of End Stage Renal Disease (ESRD) were not different between bortezomib and thalidomide-based therapy.Median follow up for whole cohort was 22 months,and 13 (18.1%) patients died ... regimens and 1 year…
hypertension and growth retardation attributed to prolonged use of corticosteroids. After treatment with thalidomide, the condition was controlled without recurrence or side effects, and corticosteroids were stopped as…
Over the past decade, few reports suggested that the drug thalidomide (HbF inducer) may be of value in a subset of transfusion-dependent and non-transfusion dependent thalassemia patients ... center in Iraqi Kurdistan…
clubbing and thrombocytosis was diagnosed with POEMS syndrome. The authors treated the patient with thalidomide-based therapy, which led to a marked improvement of POEMS syndromerelated symptoms
novel anti-protozoa prototype containing both a trypanocidal thiosemicarbazide moiety and an immuno-potentiating thalidomide-like, a hybrid structure was designed on the basis of a convergent synthesis process…
Over the past decade, few reports suggested that the drug thalidomide (HbF inducer) may be of value in a subset of transfusiondependent and nontransfusion dependent thalassemia patients. A cohort ... center in Iraqi…
Objective: In clinical trials, the combination of bortezomib, thalidomide, and dexamethasone (VTD) has shown excellent results as induction treatment in patients with multiple myeloma. However, “real-life” data in…
serious threat to human health. Determination of 6 commonly used drug concentrations, including thalidomide (THD), lenalidomide (LND), cyclophosphamide (CTX), bortezomib (BTZ), dexamethasone (DXM) and adriamycin (ADM)…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.